Search

Your search keyword '"Motti, L."' showing total 114 results

Search Constraints

Start Over You searched for: Author "Motti, L." Remove constraint Author: "Motti, L."
114 results on '"Motti, L."'

Search Results

3. High dose intravenous immune globulins and plasma exchange in Guillain-Barré Syndrome

4. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

6. Neurophysiology of the pelvic floor in clinical practice: a systematic literature review

7. Feminist representations in contemporary media: an analysis of audio-visual contents.

8. Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience

9. Quality of life, depression and fatigue in mildly disabled patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study

10. Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS

11. 10. Neurophysiological prognosis in comatose patients after cardiac arrest: The Italian Multicentric Study (ProNeCA)

12. 17. Univocal IONM code

14. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

15. Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis

16. Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study

17. 12. Outcome prediction in comatose patients after cardiac arrest, the utility of early EEG/SEP recordings during therapeutic hypothermia: The italian multicentric study (PRONECA) preliminary data

18. Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study

19. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

20. Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis

21. Neutralizing antibodies in multiple sclerosis patients treated with 375 microg interferon-beta-1b

22. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study

23. Brain atrophy in Relapsing-remitting multiple sclerosis patients treated with interferon-beta and atorvastatin (The ARIANNA study)

24. THE OPTIMIZATION OF INTERFERON FOR MS STUDY: 375 MICROG INTERFERON BETA-1B IN SUBOPTIMAL RESPONDERS

25. MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosis

27. Progetto di monitoraggio della prescrizione di farmaci disease-modifying nella sclerosi multipla in Emilia-Romagna

29. Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study

30. ERMES: Emilia-Romagna Multiple Sclerosis, the first two years of activity of a web-based registry and a biological bank, and the cooperation with the Crevif group

31. ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR THE IMPLEMENTATION A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES IN MS

32. Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis

33. THE PREVENTION OF POST-PARTUM RELAPSES WITH PROGESTIN AND ESTRADIOL IN MULTIPLE SCLEROSIS (POPART'MUS) TRIAL: RATIONALE, OBJECTIVES AND STATE OF ADVANCEMENT

38. Multiple sclerosis in twins from continental Italy and Sardinia: A nationwide study

39. RANDOMIZED CONTROLLED TRIAL OF STREPTOKINASE, ASPIRIN, AND COMBINATION OF BOTH IN TREATMENT OF ACUTE ISCHEMIC STROKE

47. A prospective study on the incidence and prognosis of Guillain-Barre syndrome in Emilia-Romagna region, Italy (1992-1993)

48. Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy

49. RANDOMIZED CONTROLLED TRIAL OF STREPTOKINASE, ASPIRIN, AND COMBINATION OF BOTH IN TREATMENT OF ACUTE ISCHEMIC STROKE

50. Prospective incidence study on Myasthenia Gravis in the Emilia Romagna region: Preliminary results

Catalog

Books, media, physical & digital resources